Mississippi 2024 Regular Session

Mississippi House Bill HB1342

Introduced
2/19/24  
Refer
2/19/24  

Caption

Controlled substances; bring forward sections for unlawful possession of.

Impact

The anticipated impact of HB1342 is multifaceted. It seeks to streamline the legal definitions associated with controlled substances, making it easier for law enforcement to enact regulations related to illicit drug use and possession. Furthermore, the bill may influence how various sectors, including healthcare and addiction treatment providers, respond to individuals with substance use disorders. By clarifying the legal boundaries, the bill could potentially lead to increased resources allocated towards treatment and education, while also imposing stricter penalties on unlawful possession, reflecting a tough stance on drug-related crimes.

Summary

House Bill 1342 aims to update and bring forward existing laws pertaining to controlled substances, particularly focusing on the unlawful possession and use of these substances. This bill establishes clear guidelines regarding various categories of drugs, including stimulants and depressants, and is designed to adapt the legal framework to align with current substances that are prevalent in society. By detailing specific drugs and their classifications, HB1342 intends to refine the state's approach to drug-related offenses, enhancing law enforcement's ability to address these issues effectively.

Contention

Despite its intention to regulate drug use more effectively, HB1342 has sparked debate among advocates and legislators. Some argue that the bill's provisions may disproportionately penalize individuals struggling with addiction rather than providing support and treatment options. Critics have highlighted the importance of addressing the root causes of substance abuse and suggest that solely punitive measures may not be the most effective approach. This divide underscores a broader discussion regarding how society treats addiction, balancing the need for law enforcement with the necessity of compassionate care for those affected by substance use disorders.

Companion Bills

No companion bills found.

Previously Filed As

MS HB4

Tianeptine; include in Schedule I controlled substance list.

MS HB791

Tianeptine; add to Schedule II list of controlled substances.

MS SB2345

Tianeptine; classify as a Schedule I substance.

MS SB2115

Tianeptine; schedule substance and criminalize intent to transfer.

MS HB1086

Tianeptine; add to list of Schedule I controlled substances.

MS HB364

Kratom and Tianeptine; include in Schedule I controlled substances list.

MS HB1071

Uniform Controlled Substances Act; revise schedules.

MS SB2283

Uniform Controlled Substances Act; revise schedules.

MS HB5

Kratom; include in Schedule I controlled substances list.

MS HB233

Testing strips for controlled substances; require Department of Health to provide free of charge.

Similar Bills

MS HB4

Tianeptine; include in Schedule I controlled substance list.

MS SB2355

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS SB2370

Uniform Controlled Substances Act; include certain substances within Schedule III.

MS HB1121

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS SB2214

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS HB1122

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

MS HB1038

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

VA HB1187

Xylazine; penalty for manufacturing, selling, etc., for human consumption.